Today: 16 July 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Pfizer Stock Price Today: Shares Slip After GSK RSV Move Offsets Eliquis Data

Pfizer Stock Price Today: Shares Slip After GSK RSV Move Offsets Eliquis Data

Pfizer Inc. slipped about 1% to close at $26.60 on Friday, landing near the session’s low as investors digested fresh developments in the respiratory syncytial virus vaccine landscape and a boost for blood thinner Eliquis. The pressure came after GSK announced the FDA had expanded Arexvy’s approval to include at-risk adults 18 to 49. Meanwhile, separate results highlighted strong outcomes for Eliquis in treating serious blood clots.
13 March 2026
···
1 … 178 179 180 181 182 … 883

Stock Market Today

  • Csquare Starts Trading on NYSE with $3.24 Billion Value as AI Data Centre Appetite Grows
    July 16, 2026, 3:48 PM EDT. Data centre operator Csquare, backed by Brookfield, began trading on the New York Stock Exchange with initial shares opening just below its $21 IPO price and ending the session at $20.37. The Dallas-based firm secured a $3.24 billion valuation after setting its IPO price beneath the originally targeted $23 to $27 range. The move highlights investor caution despite continued robust interest in AI-focused data centre infrastructure. Analysts pointed to careful investor action due to the company's leverage and ongoing losses. Founded in 2019, Csquare runs facilities across North America and Europe, catering to cloud, enterprise, and telecom customers. The company's public debut follows a series of prominent tech IPOs, reflecting a careful but receptive atmosphere for AI infrastructure equities.
Go toTop